Primary Care/Hospitalist
RSSArticles
-
Pharmacology Watch - Full October 2011 Issue in PDF
-
Chronic medications and hospitalization
-
FDA actions
-
Chinese herbs for flu treatment
-
Apixaban trial results look promising
-
The Broken Heart: It CAN Be Mended
The authors advocate that cardiovascular magnetic resonance imaging using specific criteria may be useful as a diagnostic tool for patients with stress cardiomyopathy at the time of acute clinical presentation. -
Internal Medicine Alert - Full August 29, 2011 Issue in PDF
-
Ticagrelor Tablets (Brilinta™)
A third oral antiplatelet inhibitor has been approved by the FDA to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS). Ticagrelor is an adenosine diphosphate receptor P2Y12 inhibitor similar to clopidogrel and prasugrel. It is marketed by AstraZeneca as Brilinta. -
Clinical Briefs By Louis Kuritzky, MD
Since two-thirds of americans are overweight or obese, most of us should probably be trying to better understand why. -
Beware of the Single Blood Pressure
Single blood pressure (BP) measurements are not reflective of the average BP 20% of the time. A series of BPs should be averaged for medical decision making. A series of home BP recordings is more accurate than those in the office for assessing the control of BP among hypertensive patients.